✦ LIBER ✦
ChemInform Abstract: Studies Leading to the Identification of ZD1839 (Iressa): An Orally Active, Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Targeted to the Treatment of Cancer.
✍ Scribed by Keith H. Gibson; et al. et al.
- Publisher
- John Wiley and Sons
- Year
- 2010
- Weight
- 29 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0931-7597
No coin nor oath required. For personal study only.